International Patent: MOLECULES TARGETING RIBOSOMAL PROTEIN RPL23 AND USE IN THE TREATMENT OF DISEASES, IN PARTICULAR CANCER

GENEVA, Sept. 7 -- KBHB CONSULT GMBH filed a patent application (EP2026/054196) for “MOLECULES TARGETING RIBOSOMAL PROTEIN RPL23 AND USE IN THE TREATMENT OF DISEASES, IN PARTICULAR CANCER”. With publication no. WO/2026/180293, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: none

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....